ArticleArthritis research & therapy2013

PDL241, a novel humanized monoclonal antibody, reveals CD319 as a therapeutic target for rheumatoid arthritis.

Jacky Woo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.